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ABSTRACT
Purpose: We evaluated the urodynamic changes after high energy microwave thermotherapy in 
patients with lower urinary tract symptoms and benign prostatic enlargement.
Materials and Methods: A total of 120 patients was available for analysis with urodynamic 
investigation and pressure-flow studies before and 6 months after treatment. Several obstruction 
parameters were used to evaluate treatment outcome.
Results: A significant decrease (p <0.001) in all obstruction parameters was noted. Mean 
detrusor pressure at maximum flow decreased from 64.7 to 39.1 cm. water, urethral resistance 
factor from 41,8 to 23.5 cm. water and linear passive urethral resistance relation from 3.0 to 1.4. 
Analysis of subgroups showed better results in patients with greater degrees of obstruction.
Conclusions: High energy thermotherapy results in a significant and substantial decrease in 
bladder outlet obstruction.
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Presently, there is no agreement on the role of urodynamic 
studies in assessment of patients with lower urinary tract 
symptoms and benign prostatic hypertrophy (BPH).1-2 Most 
urologists agree that the main feature of the enlarging pros­
tate is bladder outlet obstruction, eventually resulting in 
lower urinary tract symptoms. Most surgical therapies a t­
tempt to decrease obstruction and relieve symptoms. Since 
the results of surgery for BPH are generally favorable, there 
has been little enthusiasm for use of resource consuming 
investigations, such as advanced urodynamic studies.
However, an increasing number of urologists are becoming 
aware of the additional benefit of urodynamic studies with 
pressure-flow analysis in assessment and foliowup of pa­
tients with lower urinary tract symptoms and BPH. It is well 
known that 25 to 30% of patients treated surgically do not 
have bladder outlet obstruction.3-5 Although postoperative 
results are impressive and the procedure is reasonably safe, 
the morbidity of the operation is still considerably great.6 
Furthermore, the outcome for patients with minimal obstruc­
tion is less favorable,3*6*7 and most urologists will agree that 
a treatment designed to relieve obstruction in patients with­
out bladder outlet obstruction is unjustified. Also, during 
the last decade many alternatives to prostatectomy have 
surfaced, ranging from the pharmacological approach to 
numerous procedural alternatives.8-13 While none of these 
alternatives has achieved subjective and objective results 
comparable to those noted postoperatively, morbidity is sig­
nificantly decreased and one may question whether transure­
thral prostatectomy-like results always must be obtained to 
achieve a good outcome. Urodynamic studies can also be 
useful in selection of candidates for alternative treat­
ments.14’15
For the last 5 years, we performed transurethral micro­
wave thermotherapy in patients with lower urinary tract 
symptoms and BPH. Although subjective improvements us­
ing the lower energy protocol (Prostasoft 2.0*) are impres­
sive, objective improvements are less pronounced. Uro­
dynamic studies have been used to investigate the patho-
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physiology of BPH and evaluate the clinical outcome of var­
ious treatments. From a urodynamic viewpoint, only patients 
with a particular type of obstruction responded favorably 
using the lower energy protocol.14 Recently, a higher energy 
software version has been introduced to improve the outcome 
of this procedure, and significant improvement in all objec­
tive and subjective parameters was observed.9 In a subgroup 
of patients the results even seemed competitive with surgical 
therapy. We report on the urodynamic results of this high 
energy thermotherapy in patients with lower urinary tract 
symptoms and BPH. We used pressure-flow study parame­
ters to describe the power of this high energy thermo therapy 
to relieve obstruction, and compared this method to other 
(alternative) therapy options. We also studied which patients 
improved the most with this new thermotherapy protocol and 
identified specific urodynamic selection criteria.
MATERIAL AND METHODS
Since April 1993, patients with lower urinary tract symp­
toms and BPH were included in a prospective multicenter 
study of transurethral microwave thermotherapy using the 
high energy protocol. Inclusion criteria were Madsen symp­
tom score 8 or more, maximum flow rate 15 ml. per second or 
less, post-void residual 350 ml. or less and voided volume 100 
ml. or more. All patients underwent screening with physical 
examination (including digital rectal examination), blood 
chemistry studies (including prostate specific antigen with 
the Hybritech assay), urinalysis and urine culture, Transroc­
tal ultrasound of the prostate was performed with planimet- 
ric measurement of prostate volume. All patients underwent 
urethrocystoscopy to measure prostate length, and assess the 
size of the middle and lateral lobes. In cases of a suspicious 
digital rectal examination, transrectal ultrasound or ele­
vated prostate specific antigen, prostate biopsies were ob­
tained to exclude malignancy.
We used the Prostatron* device with a treatment catheter 
consisting of a microwave dipole antenna with the hot point 
positioned just below the Foley balloon. The catheter was 
mounted in a water cooled transurethral probe. The high 
energy operating software (Prostasoft 2.5) provides a maxi­
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mum power of 70 W. with a transrectal threshold set at 
43.5C. Transurethral microwave thermotherapy generally 
has been described previously.16
Urodynamic investigations were performed with an 8F 
transurethral lumen catheter with an intravesical microtip 
pressure sensor, and abdominal pressure was recorded in- 
trarectally with an 8F micro tip sensor catheter. Before cys­
tometry, the bladder was emptied through the lumen of the 
transurethral catheter, and filled with sterile saline at room 
temperature and a filling speed of 50 ml. per minute with the 
patient supine. Pressure and flow data were recorded with 
commercially available equipment. The digitally stored data 
were translated to a urodynamic analysis computer program 
developed at our department. Precise fitting of the automat­
ically computed passive urethral resistance relation curves to 
the pressure-flow plot, with correction for artifacts, was done 
by hand. Patients with detrusor failure or chronic urinary 
retention were excluded from the study. Several different 
parameters were used to document obstruction, including 
detrusor pressure at maximum flow with grading according 
to the Abrams-Griffiths nomogram,17 intersection of the qua­
dratic urethral resistance relation with the pressure axis,18 
parameters calculated from the passive urethral resistance 
relation (minimal computer derived detrusor pressure with 
ongoing flow and theoretical cross-sectional area of the ure­
thra during voiding)19 and, finally, linear passive urethral 
resistance relation, which is an approximation of the resis­
tance relation by means of a straight line through minimal 
voiding pressure and detrusor pressure at maximum flow 
rate with grading according to the Schäfer nomogram.20
Our patients were evaluated at baseline and at 26 weeks. 
To evaluate subjective parameters, patients had to complete 
international prostatic (I-PSS) and Madsen symptom score 
questionnaires. Objective parameters were evaluated by free 
urinary flow rate using a uroflowmeter and urodynamic stud­
ies with pressure-flow study analysis.
Student’s t test was used for statistical comparison of pre­
operative and postoperative data for the entire group. The 
Wilcoxon matched pairs signed rank test and the Kruskal- 
Wallis test were used to compare improvement in the differ­
ent stratified groups.
T ab le  1, Changes in mean baseline symptomatic, uroflowmetry
and urodynamic parameters in 120 patients
Mean ± SD
RESULTS
A total of 120 patients with repeated urodynamic investi­
gations was available for analysis. Only 15% of the initially 
treated patients had no second urodynamic evaluation be­
cause of difficulty introducing the micro tip catheter or be­
cause the patient refused another study, There was no dif­
ference in outcome between these patients and the 120 
studied. Mean patient age plus or minus standard deviation 
was 67.0 ± 8.8 years (range 45 to 89). Average prostate 
volume was 58.1 ± 25.0 cm.3 (range 30 to 154). Symptomatic, 
uroflowmetric and urodynamic pressure-flow parameters at 
baseline and 6 months after treatment demonstrated highly 
significant and substantial improvement (table 1).
Depending on what obstruction parameter was used, the 
incidence of pretreatment urodynamic obstruction ranged 
from 66 to 78%. Of the 120 patients 79 (66%) were considered 
to have obstruction according to linear passive urethral re­
sistance relation 3 or more, 81 (68%) according to the 
Abrams-Griffiths nomogram and 93 (78%) according to ure­
thral resistance factor more than 29 cm. water. After treat­
ment, 18 to 30% of the patients still had obstruction accord­
ing to the linear passive urethral resistance relation 
classification in 21 (18%), the Abrams-Griffiths nomogram in 
23 (19%) and urethral resistance factor in 36 (30%). Figure 1 
shows the pretreatment and posttreatment values of detru­
sor pressure at maximum flow using the Abrams-Griffiths 
nomogram.
When stratifying patients according to grade of obstruction
Baseline 6 Mos.
Symptom score:
Madsen
I-PSS
Uroflowmetry:
Maximum flow rate (ml./sec.)
Post-void residual (ml.)
Voided vol. (ml.)
Urodynamics and pressure-flow:
Detrusor pressure a t maximum flow (cm. water) 
Maximum flow (ml./sec.)
Urethral resistance factor (cm. water)
Minimum detrusor pressure (cm. water) 
Theoretical cross-sectional urethral area (mm.2) 
Linear passive urethral resistance relation
13.9 3.6 5.3 - h 4.5
17.7 6.0 8.0 6.0
9.4 -h 3.1 14.1 —f- 6.2
72 «■+" 86 29.2 78
222 127 296 134
64.7 23.4 39.1 17.1
6.1 -t- 2.6 10.5 ~ h 5.3
41.8 ± 16.4 23.5 11.7
33.6 ± 16.6 16.1 10.4
2.7 ■+" 1.4 6.1 5.2
3.0 ± 1.3 1.4 1.2
All parameters are significant according to Student’s t  test, p <0.001.
at baseline, the changes and mean improvement in objective 
parameters showed different results (table 2). There was a 
statistically significant improved efficacy in the majority of 
the objective parameters in patients with severe obstruction 
(linear passive urethral resistance relation 4 or more) com­
pared to those without or with moderate obstruction (linear 
passive urethral resistance relation 3 or less). There ap­
peared to be no significant difference in subjective param e­
ters in patients with different grades of obstruction. Further­
more, analysis of mean changes in detrusor pressure at 
maximum flow in these 3 subgroups is best expressed with 
the Abrams-Griffiths nomogram (fig. 2). One can appreciate 
that patients with severe obstruction had the most impres­
sive changes. Nevertheless, on an individual basis also, those 
without obstruction showed good improvement but generally 
the changes were moderate. The same finding accounts for 
patients with moderate obstruction, although mean improve­
ment was more pronounced.
If the achieved decrease in outlet obstruction is considered 
a stratification criterion and is compared to baseline subjec­
tive parameters, it is confirmed again th a t the greater degree 
of outlet obstruction at baseline, the better the objective 
improvement. No prognostic value could be identified in uro­
flowmetry parameters or symptom scores (table 3).
DISCUSSION
Urologists have recently renewed their interest in trea t­
ment of symptomatic BPH because of availability of less 
invasive methods. However, to compare these alternative 
therapies to the gold standard of transurethral resection, 
previous reports have questioned which method is the best 
for describing the individual physiological problem. The 
pathological triad of symptoms, prostate size and obstruction 
described by Hald et al is well recognized, and it is also 
acknowledged th a t the 3 variables are independent.21 It is 
important to know whether new treatm ents have the same 
effect on each variable as does the classic transurethral re­
section of the prostate. If there are differences in the way tha t 
a new treatm ent affects patients, it is possible th a t this 
information could be used to select those for less invasive 
therapies. The main question is whether heat treatm ents, 
such as transurethral thermotherapy, high intensity focused 
ultrasound or laser therapy, truly offer an alternative to 
classic ablative operations, such as transvesical enucleation 
or transurethral resection of the prostate.
Changes in symptoms scores, prostate size and flow rate 
are the most commonly cited evidences of efficacy for alter­
native treatments. However, at best there is only question­
able evidence to support an association between these 
parameters and obstruction as defined by urodynamic 
studies.22-24 The latter has always been accepted as the only
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PlG. 1. Detrusor pressure (P det) at maximum flow {Qmax) before (#) and 6 months after (A) high energy thermo therapy in 120 patients 
according to Abrams-Griffiths nomogram, m i l s , ml. per second. cmH20 , cm. water.
Table 2. Im p ro vem en t in param eters  s tra tified  according to baseline obstruction grade
Mean Linear Passive Urethral Resistance Relation ± SD
0-1 (20 pts.) 2-3 (48 pts.) 4-6 (52 pts.) p Value
Before After Improvement Before After Improvement Before After Improvement
Symptom score:
Madsen 12.9 ± 2.9 5.3 ± 4.1 7.6 ± 5.2 14.6 ± 3.5 6.5 ± 3.7 7.9 ± 5.5 13.7 ± 3.5 4.3 ± 3.7 9.5 ± 5.0 0.23
I-PSS 16.5 ± 6.7 8.4 ± 5.8 8.1 ± 8,4 18.6 ± 5.9 9.9 ± 4.1 8.5 ± 8.4 17.3 ± 5.9 6.1 ± 4.1 11.3 ± 7.7 0.28
Uroflowmetry:
Maximum flow (ml. sec.) 9.6 ± 2.8 13.3 ± 5.5 3.7 ± 5.5 10.1 ± 3.3 12.4 ± 7,0 2.5 ± 5.1 8.7 ± 3.3 15.9 ± 7.0 7.0 ± 7.3 0.002*
Post-void residual (ml.) 53 ± 83 7 ± 16 46 ± 76 64 ± 94 33 ± 81 29 ± 114 87 ± 94 35 ± 81 51 ± 110 0.70
Urodynamics:
Detrusor pressure a t maxi­ 33 ± 9 28 ± 13 5 ± 18 55 ± 14 40 ± 19 15 ± 14 86 ± 14 43 ± 19 43 ± 24 co .oo r1
mum flow (cm. water)
Maximum flow (ml./sec.) 7.8 ± 4 .1 10.2 ± 4.7 2.4 ± 4.4 6.4 ± 1.8 9.9 ± 6.0 3.5 ± 4.9 5.2 ± 1.8 11.1 ± 6 .0 5.9 ± 6.0 0.056
Urethral resistance factor 22 ± 4 18 ± 8.1 4 ± 8 35 ± 11 24 ± 13 11 ± 12 55 ± 11 25 ± 13 30 ± 17 <0.001*
(cm. water)
Minimum detrusor pressure 15 ± 5 12 ± 7.5 4 ± 9 28 ± 14 16 ± 11 12 ± 12 46 ± 14 18 ± 11 28 ± 19 <0.001=
(cm. water)
Theoretical cross-sectional 4.2 ± 1.7 6.9 ± 4.6 2.6 ± 4.4 2.9 ± 0.6 5.8 ± 0.6 2.9 ± 5.6 1.9 ± 0.6 6.1 ± 5.5 4.2 ± 5.6 0.07
urethral area (cm. water)
* Significant according to Rruskal-Wallis test for independent samples.
diagnostic method for determination of lower urinary tract 
obstruction, although use of routine urodynamics has yet to 
be established.25 Alternative treatm ents are able to relieve 
subjective symptoms but the question remains whether the 
objective improvements in obstruction parameters as docu­
mented by pressure-flow studies are changed. An effective 
decrease in outlet resistance as shown by pressure-flow meas­
urements has been documented for transurethral resection of 
the prostate, indicating the efficacy of the procedure in elim­
ination of specific mechanical obstruction in BPH.26
A promising minimally invasive, anesthesia-free, alterna­
tive treatment option is transurethral microwave thermo- 
therapy. Large series of patients have been treated with the 
Prostatron unit, with different treatm ent catheters and en­
ergy levels.9 Regardless of the vast experience, it is still not 
precisely clear how low energy thermo therapy affects the 
objective and subjective symptoms of patients with BPH. It 
has been assumed that a potential effect of this form of 
thermotherapy on decreasing outlet obstruction resistance 
may be caused by shrinkage of tissue due to tissue necrosis, 
leading to expansion of the urethral lumen in the pro static
urethra. Subjective symptoms may be influenced by this de­
crease in bladder outlet obstruction or the evident effect on 
the autonomic nervous system.14*27
Recently we investigated to what extent low energy trans­
urethral microwave thermotherapy as a nonablative proce­
dure is able to decrease outlet resistance. It appeared that 
transurethral microwave thermotherapy exerts a specific ef­
fect on outlet obstruction tha t cannot be compared quantita­
tively with surgical removal of the prostate. Transurethral 
microwave thermotherapy only influences the flow control­
ling area significantly, which is expressed in changes in 
passive urethral resistance relation curvature (and thus an 
increase in theoretical cross-sectional area) without affecting 
the passive urethral resistance relation foot point (equivalent 
to an unchanged minimal detrusor pressure).28 Although low 
energy transurethral microwave tbermotherapy is compara­
ble to transurethral resection of the prostate with regard to 
improvement in subjective symptoms, outlet obstruction is 
changed little. Therefore, low energy transurethral micro­
wave thermo therapy would prove to be an optimal choice for
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Qrnax (ml/s)
Fig, 2. Mean detrusor pressure (Pdet) at maximum flow (Q m ax) 
before and after high energy thermotherapy stratified according to 
obstruction class. O, no to mild obstruction—linear passive urethral 
resistance relation 1 or less, A, moderate obstruction—linear passive 
urethral resistance relation 2/3. • ,  severe obstruction—linear pas­
sive urethral resistance relation 4 or more. m2/s, ml. per second. 
cm H 20 , cm. water.
patients with BPH and lower urinary tract symptoms with 
low grade bladder outlet obstruction.
To improve outcome after thermo therapy, high energy lev­
els have been applied. Simple clinical analysis of the outcome 
by peak flow rate and Madsen symptom scores demonstrates 
a substantial advantage of Prostasoft 2.5 over the earlier 
version. We concluded that “the great change in flow rate we 
have seen in patients receiving the 2.5 software treatment 
cannot be explained by anything other than a decrease of 
urodynamic obstruction, assuming the same contractility.”9 
Our present study shows that symptomatic improvement is 
in the same range as reported in previous studies of low 
energy thermotherapy.29 The Madsen symptom score usually 
shows a baseline value of approximately 13 with an expected 
outcome of approximately 4 , Our study is comparable with a 
mean improvement from 13.9 at baseline to 5.3, 6 months 
after treatment. The same degree of improvement may be 
seen in the I-PSS. Our study shows improvement from 17.7 
a t baseline to 6.0 after 6 months, which is comparable to 
available data on other minimally invasive treatments from 
BPH that use the I-PSS for subjective evaluation.30 Further** 
more, analysis of the stratified data shows that, except for 
the urodynamic parameters, neither subjective nor uroflow- 
metric parameters could be identified as prognostic factors. 
This finding agrees with previous studies of low energy 
transurethral microwave thermotherapy.14-31
The improvements in uroflowmetry results are signifi­
cantly better compared to former low energy transurethral
microwave thermo therapy. For the entire group, there is an 
average 50% improvement in maximum flow from baseline 
9.4 to 14.1 ml. per second after 26 weeks. However, stratified 
data show that the improvement can range from 23 to 38% in 
the no to moderate obstruction group to 83% in the severe 
obstruction group. This finding shows th a t high energy 
transurethral microwave thermotherapy results in almost 
doubling of the maximum flow in severely obstructed cases, 
which is significantly better than results of low energy trans­
urethral microwave thermo therapy in the same group, 
whereas patients with no to moderate obstruction show im­
provement, which is still comparable to the best results 
achieved with the low energy protocol. Our study demon­
strates that improvement in maximum flow is indeed due to 
decreased bladder outlet obstruction as indicated by a signif­
icant improvement in all obstruction parameters. In addi­
tion, it is shown th a t patients with greater degrees of ob­
struction seem to respond best, showing a substantial 
decrease in detrusor pressure at maximum flow of 86 cm. 
water at baseline to 43 cm, water after treatm ent, with a 
similar improvement in maximum flow from 5.2 ml. per 
second before treatm ent to 11.1 ml. per second at 6 months. 
This substantial decrease in bladder outlet obstruction with 
associated subjective improvement might possibly lead to 
increased durability of this treatm ent in the long term.
Where should we position high energy thermotherapy in 
the armamentarium of treatm ent options? As noted previ­
ously, an effective decrease in outlet obstruction according to 
pressure-flow measurements has been documented for trans­
urethral resection of the prostate, indicating the efficacy of 
the procedure in elimination of specific mechanical obstruc­
tion in BPH. This fact indicates th a t transurethral resection 
of the prostate is effective because of the tissue ablation 
involved. For comparison of urodynamic changes after alter­
native treatments with those noted in patients who under­
went transurethral resection of the prostate in a nonrandom­
ized fashion, a number of patients from Bristol, England 
were evaluated before and after transurethral prostatecto­
my.32 Furthermore, the urodynamic changes after medica­
tion (terazosin) are also compared to results of the current 
study of high energy thermotherapy, and are presented as 
mean changes in detrusor pressure at maximum flow before 
and after treatm ent in an Abrams-Griffiths nomogram.33 
However, when judging and comparing data of the aforemen­
tioned studies, one should consider th a t at baseline these 
were different groups. The transurethral resection group 
mainly consisted of patients with severe obstruction, 
whereas the terazosin group included those with mild to 
moderate obstruction. Therefore, to make the data of these 
studies more comparable, we selected only patients who at 
baseline had clear obstruction (linear passive urethral resis­
tance relation 3 or more), and compared these data with 
those of our present study (fig. 3). The improvement after 
transurethral microwave thermotherapy is in the range of
T ab le 3. Baseline param eters correlated with urodynamic improvement in Linear passive urethral resistance relation classes
Baseline Parameters
Mean Improvement 
0 or Less (30 pts.)
in Linear Passive Urethral Resistance Relation 
Obstruction Class ± SD
1-2 (57 pts.) 3 or More (33 pts.)
p Value
Symptom score:
Madsen 14.0 ± 3.8 14.4 ± 3.5 13.0 ± 3.3 0.23
I-PSS 17.9 ±6.1 17.6 ± 5.8 17.6 ± 6.2 0.98
Urodynamies:
Maximum flow (ml./sec.) 10.2 ± 2.8 9.1 ± 2.8 9.2 ± 3.6 0.24
Post-void residual (ml.) 71 ± 91 65 ± 79 85 ± 93 0.48
Detrusor pressure at maximum flow (cm, water) 49.0 ± 23.2 6.12 ± 19.1 85.0 ± 15.1 <0.001*
Maximum flow (ml./sec.) 6.6 ± 2.4 6.3 ± 3.1 5.3 ± 1.7 0.09
Urethral resistance factor (cm. water) 32.3 ± 13.2 39.6 ± 13.5 54.2 ± 12.3 <0.001;!:
Linear passive urethral resistance relation 2.0 ± 1.3 2.9 ± 1.2 4.2 ± 0.6 <o.oori:
* Significant according to Kruskal-Wallis test for independent samples.
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Qmax (ml/s)
Fig. 3. Mean detrusor pressure (Pdet) at maximum flow (Qmax) 
before and after treatment in patients considered to have obstruction 
at baseline (linear passive urethral resistance relation 3 or more). □, 
43 patients undergoing transurethral prostatectomy (TURP). 9 ,  30 
patients given terazosin. A, 79 patients undergoing high energy 
transurethral microwave thermo therapy (TUMT). m ils ,  ml, per sec­
ond. cmH20 , cm. water.
what is achieved after transurethral resection of the pros™ 
tate, and significantly greater than tha t noted after medica­
tion. However, although changes are impressive, one should 
acknowledge that results are not equal to those after trans­
urethral resection of the prostate. In this regard, high energy 
thermo therapy should be positioned between medication and 
operative intervention. Similar conclusions were drawn by 
Devonec et al, who compared symptomatic and objective im­
provements in uroflowmetry parameters of different trea t­
ments.34 They also positioned high energy transurethral mi­
crowave thermo therapy between medication and surgical 
intervention, with ranges noted more towards those achieved 
with surgery. Nevertheless, case selection should identify the 
most favorable patients for high energy thermotherapy to 
improve further treatment efficacy and finally achieve re­
sults comparable to those of surgery with lower morbidity.
Since patients with greater degrees of obstruction respond 
most favorably to higher energy transurethral microwave 
thermotherapy, they are the best candidates for this treat­
ment. Thus, patients with minimal bladder outlet obstruc­
tion should preferably undergo medical treatm ent or lower 
energy thermo therapy, since subjective improvements with 
these treatments are significant with only minimal morbid­
ity. However, such an algorithm can be used only if urody­
namic studies with pressure-flow analysis are included in the 
assessment of patients with BPH. In view of the benefit to the 
patients, when using urodynamic studies with pressure-flow 
analysis as a selection criterion for therapy, we believe it 
worthwhile to include these so-called invasive, time- 
consuming investigations in the assessment of patients with
BPH.
In conclusion, high energy thermo therapy using the 
Prostatron device with the Prostasoft 2.5 operating software 
results in significant and substantial subjective and objective 
improvement in the majority of patients. Patients with 
greater degrees of bladder outlet obstruction are the best 
candidates for treatment.
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